Evogene

Evogene

Biotechnology Research

Evogene is a computational biology company aiming to revolutionize the development of life-science-based products.

About us

Evogene (Nasdaq: EVGN, TASE: EVGN) is a computational biology company aiming to revolutionize the development of life-science based products by utilizing cutting edge technologies to increase probability of success while reducing development time and cost. Evogene established three unique technological engines – MicroBoost AI, ChemPass AI and GeneRator AI – leveraging Big Data and Artificial Intelligence and incorporating deep multidisciplinary understanding in life sciences. Each technological engine is focused on the discovery and development of products based on one of the following core components: microbes (MicroBoost AI), small molecules (ChemPass AI), and genetic elements (GeneRator AI). Evogene uses its technological engines to develop products through subsidiaries and with strategic partners. Currently, Evogene’s main subsidiaries utilize the technological engines to develop human microbiome-based therapeutics by Biomica Ltd., ag-chemicals by AgPlenus Ltd. and ag-biologicals by Lavie Bio Ltd. For more information, please visit: www.evogene.com

Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
Rehovot
Type
Public Company
Founded
2002
Specialties
biotechnology, computational genomics, Artificial Intelligence, Microbiome, Small Molecules , Genetic Elements , and Life-Science

Locations

Employees at Evogene

Updates

Similar pages

Funding

Evogene 9 total rounds

Last Round

Post IPO equity

US$ 5.5M

See more info on crunchbase